Codexis, Inc. - CDXS Company Short-Term Debt

Codexis, Inc. (CDXS) - corporate logo

The market capitalization trend for Codexis, Inc. (CDXS) reflects a metric that currently stands at 0.01. Codexis, Inc. (CDXS) adheres to fundamental environmental standards, focusing on the safe disposal of laboratory waste. The business specializes in creating modified proteins, helping partners optimize costs. At the core of its operations is CodeEvolver, which enables the development of unique enzymes for the medical and food industries.

Codexis Bio (CDXS) Company Short-Term Indebtedness: for the period 07/04/2022 - 10/28/2026

Summary analytical data breakdowns for Codexis Inc (CDXS)

- price and consensus price forecast:
Stock Price Codexis Bio|CDXS - Consensus Target
- market capitalization data:
Market Value Codexis|CDXS - Total Enterprise Value
- book capitalization data:
Book Value per Share Codexis, Inc.|CDXS - Accounting Capitalization|Market Capitalization to Book Value Ratio codexis.com|CDXS - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Codexis, Inc.|CDXS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Codexis Bio|CDXS - Company Total Debt Obligations|Debt to Book Capitalization Ratio Codexis|CDXS - Long-Term Debt Volume|Company Current Liabilities Codexis, Inc.
Fundamental company valuation:codexis.com CDXS
Manufactured product of Codexis Inc

Liquidity is critical for Codexis, Inc. (CDXS) amidst fierce competition with pharmaceutical behemoths. This metric aggregates all obligations maturing within one year, assessing the business's ability to service its loans. By analyzing current liabilities, an investor can gauge the company's sensitivity to the cost of capital. Reducing debt minimizes the risk of a cash crunch as the market shifts toward chemical synthesis. An optimal lending balance here determines the pace of technological development.

Competitor analysis

TEM: Company Short-Term Debts|QGEN: Company Current Liabilities|Company Short-Term Debt IONS|Repligen Inc. (RGEN) - Short-Term Debt|Company Short-Term Debts Avidity Biosciences (RNA)|Company Short-Term Indebtedness crisprtx.com|GeneDx - Company Short-Term Debts|Short-Term Debt Ultragenyx Pharmaceutical Inc. RARE|BEAM - Company Current Liabilities|Company Short-Term Indebtedness Sarepta Corp SRPT|Company Short-Term Debts TWST (Twist Bioscience)|TXG: Short-Term Debt Volume|Intellia Therapeutics, Inc. - Company Short-Term Debt|Short-Term Debt Volume Stoke Therapeutics Inc|BLFS - Company Current Liabilities|Company Short-Term Loans and Borrowings Wave Pharma|MAZE (Maze Therapeutics Inc) - Company Short-Term Debts|Short-Term Debt Volume SION (sionnatx.com)|PRME - Company Short-Term Debt|Company Short-Term Indebtedness Taysha Gene Therapies Inc TSHA|QURE: Company Short-Term Debts|MeiraGTx Corp (MGTX) - Company Current Liabilities|REGENXBIO Inc. - Company Current Liabilities|solidbio.com (SLDB) - Short-Term Debt Volume|Company Short-Term Debts OCGN|Company Current Liabilities Pacific Biosciences of California, Inc.|Company Short-Term Debts Benitec BNTC|Company Short-Term Indebtedness Design Corp DSGN|RCKT - Company Current Liabilities|4dmoleculartherapeutics.com - Company Short-Term Indebtedness|Company Short-Term Debt LXEO (Lexeo)|KRRO - Short-Term Debt Volume|Company Short-Term Debts Editas|SLN (Silence Therapeutics Corp) - Company Short-Term Indebtedness|Company Short-Term Debt ProQR (PRQR)|Company Short-Term Indebtedness sangamo.com|Company Short-Term Debts NAUT|Company Short-Term Debts Metagenomi Inc. (MGX)|Precision BioSciences - Company Short-Term Debts|Generation Bio Co - Company Current Liabilities|BOLD (Boundless Bio, Inc.) - Company Short-Term Debt|XCUR - Short-Term Debt|Company Short-Term Debts imunon.com|Phio Pharmaceuticals Corp. (PHIO) - Company Short-Term Indebtedness|Company Short-Term Debts MBIO (Mustang Bio Inc)|Short-Term Debt TransCode (RNAZ)|Company Current Liabilities Bionano Genomics, Inc. BNGO|Company Short-Term Indebtedness adnas.com (APDN)|Company Short-Term Debts BLUE|ImmunoPrecise Antibodies Ltd - Short-Term Debt Volume|Company Short-Term Debt OMGA (Omega)|Singular Genomics Corp (OMIC) - Short-Term Debt Volume|Company Current Liabilities Regulus Therapeutics RGLS|syros.com (SYRS) - Company Short-Term Loans and Borrowings|TBIO: Company Short-Term Debts|Short-Term Debt Volume TCON|Company Short-Term Debt Unity Bio UBX